|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||10.10 - 11.70|
|52 Week Range||6.80 - 69.50|
|Beta (5Y Monthly)||2.34|
|PE Ratio (TTM)||4.68|
|Forward Dividend & Yield||0.04 (0.39%)|
|Ex-Dividend Date||Jan 23, 2020|
|1y Target Est||100.00|
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA"), (the "Company" or "Core Lab") announces that on March 20, 2020, it filed its definitive proxy on form DEF-14A with the U.S. Securities and Exchange Commission (the "SEC") setting the Company's 2020 annual shareholder meeting in Amsterdam, the Netherlands, for May 20, 2020 at 9:00 a.m. CEST.
Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2020 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 23, 2020.
To the annoyance of some shareholders, Core Laboratories (NYSE:CLB) shares are down a considerable 71% in the last...
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") is announcing immediate actions in response to current market volatility, operational disruption related to COVID-19, and the oil and gas industry outlook. In addition, Core Lab is making further corporate and operating cost reductions and reducing its 2020 capital expenditure program to align with the Company's client activity. The Company also feels it is appropriate to withdraw its first quarter 2020 guidance, last provided on January 29, 2020.
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Potential Core Laboratories N.V. (NYSE:CLB) shareholders may wish to note that the COO, President & Supervisory...
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in fourth quarter 2019 revenue of $156,800,000. Core's operating income was $21,100,000, with earnings per diluted share ("EPS") of $0.23, all in accordance with U.S. generally accepted accounting principles ("GAAP"); operating income, ex-items, a non-GAAP financial measure, was $25,000,000, yielding operating margins of 16% and EPS, ex-items, of $0.38. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.
Two oil-and-gas companies have cut their payouts in the past month. A new report attempts to predict which others could do the same in the months ahead.
The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam Exchange: "CLB NA") has announced a cash dividend of $0.25 per share of common stock payable in the first quarter of 2020. This first quarter dividend would mean a total payout of $1.00 per share of common stock, if maintained for the entire year. The quarterly $0.25 per share cash dividend will be payable on Friday, 14 February 2020, to shareholders of record on Friday, 24 January 2020. Dutch withholding tax will be deducted from the dividend at a rate of 15%.
Core Laboratories told you what you needed to know -- maybe all you needed to know -- when it sliced its dividend from $0.55 to $0.25 as the year began. Core is a thoughtful company that bases its decisions on traditional return on equity not on a "drill baby drill" hypotheses and it wouldn't be cutting that dividend, which has been both sacrosanct and a chief reason to own the stock, if it weren't for longer-term concerns that the oil business itself just isn't coming back the way it's supposed to when oil prices go higher. Core only cut its estimates for the fourth quarter (the one just concluded) by about seven cents, guiding down from 44 to 45 cents to 37 to 38 cents, hardly a decline meriting taking such a hatchet to the dividend... unless the company, long one of the remaining bulls on oil, has come to the conclusion that oil business has fundamentally changed.
The Amsterdam oil-services provider says it has been hit by a falloff in U.S. drilling activity and slower than expected client discussions on major projects.
Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2019 conference call over the Internet at 7:30 a.m. CST / 2:30 p.m. CET on January 30, 2020.
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") is announcing revised guidance from continuing operations for the fourth quarter of 2019, initial first quarter 2020 guidance and a reduction of its future quarterly dividend.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exorbitant fees. No one knows what the future holds and how market participants will react to the bountiful news that floods in each […]
Is Core Laboratories N.V. (NYSE:CLB) a good dividend stock? How can we tell? Dividend paying companies with growing...
Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed...
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 45% and 39% respectively. Hedge funds' top 3 stock picks returned 34.4% this year and beat the S&P […]
- COMPANY REVENUE OF $173 MILLION , UP 2.5% SEQUENTIALLY - GAAP EPS OF $0.54 ; $0.50 , EX-ITEMS, UP 9% SEQUENTIALLY - CORE GENERATES FCF FOR 72ND CONSECUTIVE QUARTER - RESERVOIR DESCRIPTION REVENUE HIGHEST ...